nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine barbiturate—Gastric irritation—Liotrix—hypothyroidism	0.0219	0.0302	CcSEcCtD
Quinidine barbiturate—Epigastric discomfort—Liotrix—hypothyroidism	0.0161	0.0223	CcSEcCtD
Quinidine barbiturate—Angina pectoris—Liothyronine—hypothyroidism	0.0143	0.0198	CcSEcCtD
Quinidine barbiturate—KCNK1—adrenal cortex—hypothyroidism	0.0133	0.064	CbGeAlD
Quinidine barbiturate—KCNK1—heart—hypothyroidism	0.0129	0.0619	CbGeAlD
Quinidine barbiturate—KCNK1—cardiovascular system—hypothyroidism	0.0121	0.0584	CbGeAlD
Quinidine barbiturate—CYP2D6—urine—hypothyroidism	0.0113	0.0541	CbGeAlD
Quinidine barbiturate—Coagulopathy—Liotrix—hypothyroidism	0.0109	0.015	CcSEcCtD
Quinidine barbiturate—Necrosis—Liotrix—hypothyroidism	0.0108	0.0149	CcSEcCtD
Quinidine barbiturate—KCNK1—pituitary gland—hypothyroidism	0.0108	0.0517	CbGeAlD
Quinidine barbiturate—Coma—Levothyroxine—hypothyroidism	0.0105	0.0145	CcSEcCtD
Quinidine barbiturate—Coma—Dextrothyroxine—hypothyroidism	0.0105	0.0145	CcSEcCtD
Quinidine barbiturate—Hyperkinesia—Dextrothyroxine—hypothyroidism	0.0101	0.0139	CcSEcCtD
Quinidine barbiturate—Hyperkinesia—Levothyroxine—hypothyroidism	0.0101	0.0139	CcSEcCtD
Quinidine barbiturate—Extravasation—Liotrix—hypothyroidism	0.00972	0.0134	CcSEcCtD
Quinidine barbiturate—KCNK1—adrenal gland—hypothyroidism	0.00961	0.0462	CbGeAlD
Quinidine barbiturate—Disorientation—Levothyroxine—hypothyroidism	0.00935	0.0129	CcSEcCtD
Quinidine barbiturate—Disorientation—Dextrothyroxine—hypothyroidism	0.00935	0.0129	CcSEcCtD
Quinidine barbiturate—KCNK1—thyroid gland—hypothyroidism	0.00927	0.0446	CbGeAlD
Quinidine barbiturate—Hypocalcaemia—Liotrix—hypothyroidism	0.00926	0.0128	CcSEcCtD
Quinidine barbiturate—Oliguria—Liotrix—hypothyroidism	0.0092	0.0127	CcSEcCtD
Quinidine barbiturate—KCNK1—female gonad—hypothyroidism	0.00896	0.0431	CbGeAlD
Quinidine barbiturate—Hypoglycaemia—Levothyroxine—hypothyroidism	0.00858	0.0118	CcSEcCtD
Quinidine barbiturate—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.00858	0.0118	CcSEcCtD
Quinidine barbiturate—Affect lability—Levothyroxine—hypothyroidism	0.00824	0.0114	CcSEcCtD
Quinidine barbiturate—Affect lability—Dextrothyroxine—hypothyroidism	0.00824	0.0114	CcSEcCtD
Quinidine barbiturate—Tachycardia—Liothyronine—hypothyroidism	0.00817	0.0113	CcSEcCtD
Quinidine barbiturate—Irritability—Dextrothyroxine—hypothyroidism	0.00799	0.011	CcSEcCtD
Quinidine barbiturate—Irritability—Levothyroxine—hypothyroidism	0.00799	0.011	CcSEcCtD
Quinidine barbiturate—Cardiac arrest—Dextrothyroxine—hypothyroidism	0.00796	0.011	CcSEcCtD
Quinidine barbiturate—Cardiac arrest—Levothyroxine—hypothyroidism	0.00796	0.011	CcSEcCtD
Quinidine barbiturate—KCNK1—testis—hypothyroidism	0.00795	0.0382	CbGeAlD
Quinidine barbiturate—Mood swings—Levothyroxine—hypothyroidism	0.00793	0.0109	CcSEcCtD
Quinidine barbiturate—Mood swings—Dextrothyroxine—hypothyroidism	0.00793	0.0109	CcSEcCtD
Quinidine barbiturate—Hypotension—Liothyronine—hypothyroidism	0.00783	0.0108	CcSEcCtD
Quinidine barbiturate—Coma—Liotrix—hypothyroidism	0.00775	0.0107	CcSEcCtD
Quinidine barbiturate—SCN5A—heart—hypothyroidism	0.00769	0.037	CbGeAlD
Quinidine barbiturate—GRIA2—Unblocking of NMDA receptor, glutamate binding and activation—NEFL—hypothyroidism	0.00758	0.112	CbGpPWpGaD
Quinidine barbiturate—KCNK1—liver—hypothyroidism	0.00751	0.0361	CbGeAlD
Quinidine barbiturate—Hyperkinesia—Liotrix—hypothyroidism	0.0074	0.0102	CcSEcCtD
Quinidine barbiturate—Muscular weakness—Levothyroxine—hypothyroidism	0.00738	0.0102	CcSEcCtD
Quinidine barbiturate—Muscular weakness—Dextrothyroxine—hypothyroidism	0.00738	0.0102	CcSEcCtD
Quinidine barbiturate—KCNK1—cerebellum—hypothyroidism	0.00734	0.0353	CbGeAlD
Quinidine barbiturate—SCN5A—cardiovascular system—hypothyroidism	0.00726	0.0349	CbGeAlD
Quinidine barbiturate—Angina pectoris—Dextrothyroxine—hypothyroidism	0.00705	0.00972	CcSEcCtD
Quinidine barbiturate—Angina pectoris—Levothyroxine—hypothyroidism	0.00705	0.00972	CcSEcCtD
Quinidine barbiturate—Disorientation—Liotrix—hypothyroidism	0.00688	0.0095	CcSEcCtD
Quinidine barbiturate—Renal failure acute—Liotrix—hypothyroidism	0.00667	0.0092	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Liothyronine—hypothyroidism	0.00662	0.00914	CcSEcCtD
Quinidine barbiturate—CHRM2—heart—hypothyroidism	0.00655	0.0315	CbGeAlD
Quinidine barbiturate—Renal impairment—Liotrix—hypothyroidism	0.00647	0.00893	CcSEcCtD
Quinidine barbiturate—GRIA2—testis—hypothyroidism	0.00647	0.0311	CbGeAlD
Quinidine barbiturate—Hypoglycaemia—Liotrix—hypothyroidism	0.00631	0.0087	CcSEcCtD
Quinidine barbiturate—Sweating—Dextrothyroxine—hypothyroidism	0.00618	0.00853	CcSEcCtD
Quinidine barbiturate—Sweating—Levothyroxine—hypothyroidism	0.00618	0.00853	CcSEcCtD
Quinidine barbiturate—CHRM2—cardiovascular system—hypothyroidism	0.00618	0.0297	CbGeAlD
Quinidine barbiturate—Affect lability—Liotrix—hypothyroidism	0.00606	0.00836	CcSEcCtD
Quinidine barbiturate—KCNH2—Hematopoietic Stem Cell Differentiation—TPO—hypothyroidism	0.00605	0.0895	CbGpPWpGaD
Quinidine barbiturate—GRIA2—cerebellum—hypothyroidism	0.00597	0.0287	CbGeAlD
Quinidine barbiturate—Irritability—Liotrix—hypothyroidism	0.00588	0.00811	CcSEcCtD
Quinidine barbiturate—Cardiac arrest—Liotrix—hypothyroidism	0.00585	0.00808	CcSEcCtD
Quinidine barbiturate—Mood swings—Liotrix—hypothyroidism	0.00583	0.00805	CcSEcCtD
Quinidine barbiturate—SCN5A—blood—hypothyroidism	0.00574	0.0276	CbGeAlD
Quinidine barbiturate—Muscular weakness—Liotrix—hypothyroidism	0.00543	0.00749	CcSEcCtD
Quinidine barbiturate—Flushing—Dextrothyroxine—hypothyroidism	0.00537	0.00742	CcSEcCtD
Quinidine barbiturate—Flushing—Levothyroxine—hypothyroidism	0.00537	0.00742	CcSEcCtD
Quinidine barbiturate—Bronchospasm—Liotrix—hypothyroidism	0.00523	0.00722	CcSEcCtD
Quinidine barbiturate—Angina pectoris—Liotrix—hypothyroidism	0.00518	0.00715	CcSEcCtD
Quinidine barbiturate—GABRA2—adrenal gland—hypothyroidism	0.00508	0.0244	CbGeAlD
Quinidine barbiturate—Tension—Dextrothyroxine—hypothyroidism	0.00495	0.00683	CcSEcCtD
Quinidine barbiturate—Tension—Levothyroxine—hypothyroidism	0.00495	0.00683	CcSEcCtD
Quinidine barbiturate—Nervousness—Dextrothyroxine—hypothyroidism	0.00489	0.00676	CcSEcCtD
Quinidine barbiturate—Nervousness—Levothyroxine—hypothyroidism	0.00489	0.00676	CcSEcCtD
Quinidine barbiturate—KCNH2—heart—hypothyroidism	0.00473	0.0227	CbGeAlD
Quinidine barbiturate—Tremor—Levothyroxine—hypothyroidism	0.00472	0.00652	CcSEcCtD
Quinidine barbiturate—Tremor—Dextrothyroxine—hypothyroidism	0.00472	0.00652	CcSEcCtD
Quinidine barbiturate—Renal failure—Liotrix—hypothyroidism	0.00466	0.00644	CcSEcCtD
Quinidine barbiturate—Agitation—Levothyroxine—hypothyroidism	0.00463	0.00639	CcSEcCtD
Quinidine barbiturate—Agitation—Dextrothyroxine—hypothyroidism	0.00463	0.00639	CcSEcCtD
Quinidine barbiturate—Angioedema—Levothyroxine—hypothyroidism	0.00461	0.00636	CcSEcCtD
Quinidine barbiturate—Angioedema—Dextrothyroxine—hypothyroidism	0.00461	0.00636	CcSEcCtD
Quinidine barbiturate—Sweating—Liotrix—hypothyroidism	0.00455	0.00628	CcSEcCtD
Quinidine barbiturate—KCNH2—cardiovascular system—hypothyroidism	0.00446	0.0215	CbGeAlD
Quinidine barbiturate—Palpitations—Dextrothyroxine—hypothyroidism	0.00445	0.00615	CcSEcCtD
Quinidine barbiturate—Palpitations—Levothyroxine—hypothyroidism	0.00445	0.00615	CcSEcCtD
Quinidine barbiturate—Convulsion—Dextrothyroxine—hypothyroidism	0.00437	0.00603	CcSEcCtD
Quinidine barbiturate—Convulsion—Levothyroxine—hypothyroidism	0.00437	0.00603	CcSEcCtD
Quinidine barbiturate—Arthralgia—Levothyroxine—hypothyroidism	0.00429	0.00592	CcSEcCtD
Quinidine barbiturate—Arthralgia—Dextrothyroxine—hypothyroidism	0.00429	0.00592	CcSEcCtD
Quinidine barbiturate—Anxiety—Levothyroxine—hypothyroidism	0.00428	0.0059	CcSEcCtD
Quinidine barbiturate—Anxiety—Dextrothyroxine—hypothyroidism	0.00428	0.0059	CcSEcCtD
Quinidine barbiturate—Confusional state—Dextrothyroxine—hypothyroidism	0.00415	0.00572	CcSEcCtD
Quinidine barbiturate—Confusional state—Levothyroxine—hypothyroidism	0.00415	0.00572	CcSEcCtD
Quinidine barbiturate—Shock—Levothyroxine—hypothyroidism	0.00405	0.00558	CcSEcCtD
Quinidine barbiturate—Shock—Dextrothyroxine—hypothyroidism	0.00405	0.00558	CcSEcCtD
Quinidine barbiturate—Tachycardia—Dextrothyroxine—hypothyroidism	0.00401	0.00554	CcSEcCtD
Quinidine barbiturate—Tachycardia—Levothyroxine—hypothyroidism	0.00401	0.00554	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00398	0.00549	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00398	0.00549	CcSEcCtD
Quinidine barbiturate—Flushing—Liotrix—hypothyroidism	0.00395	0.00545	CcSEcCtD
Quinidine barbiturate—KCNH2—pituitary gland—hypothyroidism	0.00395	0.019	CbGeAlD
Quinidine barbiturate—GABRA2—cerebellum—hypothyroidism	0.00388	0.0187	CbGeAlD
Quinidine barbiturate—SCN5A—Cardiac Progenitor Differentiation—NKX2-5—hypothyroidism	0.00377	0.0559	CbGpPWpGaD
Quinidine barbiturate—GABRA1—cerebellum—hypothyroidism	0.00375	0.018	CbGeAlD
Quinidine barbiturate—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—NEFL—hypothyroidism	0.00375	0.0555	CbGpPWpGaD
Quinidine barbiturate—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00375	0.00517	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00375	0.00517	CcSEcCtD
Quinidine barbiturate—KCNK1—Neuronal System—SLC5A7—hypothyroidism	0.00367	0.0544	CbGpPWpGaD
Quinidine barbiturate—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00367	0.00506	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Levothyroxine—hypothyroidism	0.00367	0.00506	CcSEcCtD
Quinidine barbiturate—Tension—Liotrix—hypothyroidism	0.00364	0.00502	CcSEcCtD
Quinidine barbiturate—Nervousness—Liotrix—hypothyroidism	0.0036	0.00497	CcSEcCtD
Quinidine barbiturate—KCNH2—adrenal gland—hypothyroidism	0.00353	0.017	CbGeAlD
Quinidine barbiturate—KCNH2—blood—hypothyroidism	0.00353	0.017	CbGeAlD
Quinidine barbiturate—Vision blurred—Liotrix—hypothyroidism	0.00349	0.00482	CcSEcCtD
Quinidine barbiturate—Tremor—Liotrix—hypothyroidism	0.00347	0.00479	CcSEcCtD
Quinidine barbiturate—Agitation—Liotrix—hypothyroidism	0.00341	0.0047	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Levothyroxine—hypothyroidism	0.00339	0.00468	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00339	0.00468	CcSEcCtD
Quinidine barbiturate—Angioedema—Liotrix—hypothyroidism	0.00339	0.00467	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00336	0.00464	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00336	0.00464	CcSEcCtD
Quinidine barbiturate—Syncope—Liotrix—hypothyroidism	0.00332	0.00459	CcSEcCtD
Quinidine barbiturate—KCNH2—female gonad—hypothyroidism	0.00329	0.0158	CbGeAlD
Quinidine barbiturate—Palpitations—Liotrix—hypothyroidism	0.00328	0.00452	CcSEcCtD
Quinidine barbiturate—Urticaria—Levothyroxine—hypothyroidism	0.00327	0.00451	CcSEcCtD
Quinidine barbiturate—Urticaria—Dextrothyroxine—hypothyroidism	0.00327	0.00451	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Liotrix—hypothyroidism	0.00326	0.0045	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Levothyroxine—hypothyroidism	0.00325	0.00449	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00325	0.00449	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Levothyroxine—hypothyroidism	0.00325	0.00449	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00325	0.00449	CcSEcCtD
Quinidine barbiturate—Convulsion—Liotrix—hypothyroidism	0.00321	0.00443	CcSEcCtD
Quinidine barbiturate—Arthralgia—Liotrix—hypothyroidism	0.00316	0.00436	CcSEcCtD
Quinidine barbiturate—Chest pain—Liotrix—hypothyroidism	0.00316	0.00436	CcSEcCtD
Quinidine barbiturate—Anxiety—Liotrix—hypothyroidism	0.00315	0.00434	CcSEcCtD
Quinidine barbiturate—Confusional state—Liotrix—hypothyroidism	0.00305	0.00421	CcSEcCtD
Quinidine barbiturate—Oedema—Liotrix—hypothyroidism	0.00303	0.00418	CcSEcCtD
Quinidine barbiturate—Shock—Liotrix—hypothyroidism	0.00298	0.00411	CcSEcCtD
Quinidine barbiturate—Tachycardia—Liotrix—hypothyroidism	0.00295	0.00408	CcSEcCtD
Quinidine barbiturate—Asthenia—Levothyroxine—hypothyroidism	0.00295	0.00407	CcSEcCtD
Quinidine barbiturate—Asthenia—Dextrothyroxine—hypothyroidism	0.00295	0.00407	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Liotrix—hypothyroidism	0.00292	0.00404	CcSEcCtD
Quinidine barbiturate—KCNH2—testis—hypothyroidism	0.00292	0.014	CbGeAlD
Quinidine barbiturate—Pruritus—Levothyroxine—hypothyroidism	0.00291	0.00402	CcSEcCtD
Quinidine barbiturate—Pruritus—Dextrothyroxine—hypothyroidism	0.00291	0.00402	CcSEcCtD
Quinidine barbiturate—Anorexia—Liotrix—hypothyroidism	0.00288	0.00398	CcSEcCtD
Quinidine barbiturate—Hypotension—Liotrix—hypothyroidism	0.00283	0.0039	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00281	0.00388	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Levothyroxine—hypothyroidism	0.00281	0.00388	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00276	0.0038	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Liotrix—hypothyroidism	0.0027	0.00372	CcSEcCtD
Quinidine barbiturate—KCNH2—cerebellum—hypothyroidism	0.0027	0.013	CbGeAlD
Quinidine barbiturate—Decreased appetite—Liotrix—hypothyroidism	0.00263	0.00363	CcSEcCtD
Quinidine barbiturate—Vomiting—Dextrothyroxine—hypothyroidism	0.00262	0.00361	CcSEcCtD
Quinidine barbiturate—Vomiting—Levothyroxine—hypothyroidism	0.00262	0.00361	CcSEcCtD
Quinidine barbiturate—Rash—Dextrothyroxine—hypothyroidism	0.00259	0.00358	CcSEcCtD
Quinidine barbiturate—Rash—Levothyroxine—hypothyroidism	0.00259	0.00358	CcSEcCtD
Quinidine barbiturate—Dermatitis—Dextrothyroxine—hypothyroidism	0.00259	0.00358	CcSEcCtD
Quinidine barbiturate—Dermatitis—Levothyroxine—hypothyroidism	0.00259	0.00358	CcSEcCtD
Quinidine barbiturate—Constipation—Liotrix—hypothyroidism	0.00259	0.00357	CcSEcCtD
Quinidine barbiturate—Headache—Levothyroxine—hypothyroidism	0.00258	0.00356	CcSEcCtD
Quinidine barbiturate—Headache—Dextrothyroxine—hypothyroidism	0.00258	0.00356	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Liotrix—hypothyroidism	0.00249	0.00344	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Liotrix—hypothyroidism	0.00247	0.00341	CcSEcCtD
Quinidine barbiturate—Nausea—Dextrothyroxine—hypothyroidism	0.00244	0.00337	CcSEcCtD
Quinidine barbiturate—Nausea—Levothyroxine—hypothyroidism	0.00244	0.00337	CcSEcCtD
Quinidine barbiturate—Urticaria—Liotrix—hypothyroidism	0.0024	0.00332	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Liotrix—hypothyroidism	0.00239	0.0033	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Liotrix—hypothyroidism	0.00239	0.0033	CcSEcCtD
Quinidine barbiturate—KCNK1—Neuronal System—NEFL—hypothyroidism	0.00237	0.0351	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00223	0.0331	CbGpPWpGaD
Quinidine barbiturate—Hypersensitivity—Liotrix—hypothyroidism	0.00223	0.00308	CcSEcCtD
Quinidine barbiturate—Asthenia—Liotrix—hypothyroidism	0.00217	0.003	CcSEcCtD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00216	0.0321	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—blood—hypothyroidism	0.00215	0.0103	CbGeAlD
Quinidine barbiturate—Pruritus—Liotrix—hypothyroidism	0.00214	0.00295	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Liotrix—hypothyroidism	0.00207	0.00286	CcSEcCtD
Quinidine barbiturate—CYP2D6—female gonad—hypothyroidism	0.00201	0.00965	CbGeAlD
Quinidine barbiturate—Dizziness—Liotrix—hypothyroidism	0.002	0.00276	CcSEcCtD
Quinidine barbiturate—Vomiting—Liotrix—hypothyroidism	0.00192	0.00265	CcSEcCtD
Quinidine barbiturate—Rash—Liotrix—hypothyroidism	0.00191	0.00263	CcSEcCtD
Quinidine barbiturate—Dermatitis—Liotrix—hypothyroidism	0.00191	0.00263	CcSEcCtD
Quinidine barbiturate—Headache—Liotrix—hypothyroidism	0.0019	0.00262	CcSEcCtD
Quinidine barbiturate—Nausea—Liotrix—hypothyroidism	0.0018	0.00248	CcSEcCtD
Quinidine barbiturate—CYP2D6—testis—hypothyroidism	0.00178	0.00856	CbGeAlD
Quinidine barbiturate—CYP2D6—liver—hypothyroidism	0.00168	0.00809	CbGeAlD
Quinidine barbiturate—CYP2D6—cerebellum—hypothyroidism	0.00164	0.00791	CbGeAlD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00164	0.0243	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00147	0.0218	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00144	0.0213	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.0014	0.0208	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00139	0.0207	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—SLC5A7—hypothyroidism	0.00125	0.0186	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00115	0.0171	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00115	0.0171	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—SLC5A7—hypothyroidism	0.00111	0.0164	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00106	0.0156	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000988	0.0146	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000983	0.0146	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.000948	0.014	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—SLC5A7—hypothyroidism	0.000884	0.0131	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Cardiac Progenitor Differentiation—IGF1—hypothyroidism	0.000869	0.0129	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000843	0.0125	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—NEFL—hypothyroidism	0.000809	0.012	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—SLC5A7—hypothyroidism	0.000753	0.0112	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000743	0.011	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.000742	0.011	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—NEFL—hypothyroidism	0.000714	0.0106	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—CLTC—hypothyroidism	0.000703	0.0104	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—VAV3—hypothyroidism	0.000696	0.0103	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000634	0.00938	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000573	0.00849	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—NEFL—hypothyroidism	0.000569	0.00843	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000555	0.00822	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—CLTC—hypothyroidism	0.000502	0.00743	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—NEFL—hypothyroidism	0.000485	0.00719	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000475	0.00704	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—PIK3C2A—hypothyroidism	0.000464	0.00687	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000405	0.006	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000394	0.00583	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000377	0.00559	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000336	0.00497	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—VAV3—hypothyroidism	0.000331	0.00491	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000322	0.00477	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000295	0.00438	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000287	0.00425	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000287	0.00425	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000255	0.00377	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—TRH—hypothyroidism	0.000245	0.00363	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—VAV3—hypothyroidism	0.000236	0.0035	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—TSHB—hypothyroidism	0.000219	0.00324	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—TSHR—hypothyroidism	0.000219	0.00324	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000206	0.00306	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.00019	0.00281	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000169	0.00251	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000162	0.0024	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000149	0.00221	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—POMC—hypothyroidism	0.000141	0.0021	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—TRH—hypothyroidism	0.000139	0.00205	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—IYD—hypothyroidism	0.000129	0.00192	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—AVP—hypothyroidism	0.000129	0.00191	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000127	0.00189	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—TRH—hypothyroidism	0.000126	0.00187	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—TSHB—hypothyroidism	0.000124	0.00183	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—TSHR—hypothyroidism	0.000124	0.00183	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000112	0.00167	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—TSHR—hypothyroidism	0.000112	0.00166	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—TSHB—hypothyroidism	0.000112	0.00166	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ATP5O—hypothyroidism	0.00011	0.00163	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—POMC—hypothyroidism	0.00011	0.00162	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—TPO—hypothyroidism	0.000103	0.00153	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CLTC—hypothyroidism	8.61e-05	0.00127	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—POMC—hypothyroidism	8.57e-05	0.00127	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—VAV3—hypothyroidism	7.56e-05	0.00112	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TRH—hypothyroidism	7.44e-05	0.0011	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—AVP—hypothyroidism	7.28e-05	0.00108	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—VAV3—hypothyroidism	6.87e-05	0.00102	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TSHB—hypothyroidism	6.63e-05	0.000982	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TSHR—hypothyroidism	6.63e-05	0.000982	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—AVP—hypothyroidism	6.62e-05	0.00098	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SH2B3—hypothyroidism	5.91e-05	0.000875	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—POMC—hypothyroidism	4.84e-05	0.000717	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—TSHB—hypothyroidism	4.79e-05	0.000709	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—POMC—hypothyroidism	4.4e-05	0.000651	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PRL—hypothyroidism	4.38e-05	0.000649	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	4.27e-05	0.000632	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—VAV3—hypothyroidism	4.06e-05	0.000601	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—AVP—hypothyroidism	3.91e-05	0.000579	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SLC5A5—hypothyroidism	3.58e-05	0.000531	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—POMC—hypothyroidism	2.6e-05	0.000385	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IGF1—hypothyroidism	2.5e-05	0.00037	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—POMC—hypothyroidism	1.88e-05	0.000278	CbGpPWpGaD
